Introduction Vaccination has progressively improved survival and decreased morbidity from infectious diseases for more than two centuries. The greatest historical successes have been in protecting infants and children from early death, needless suffering, and permanent disability. At this time, in many countries, vaccine-preventable illnesses and deaths are now predominantly an adult phenomenon. Workplace vaccination programs are important for workers with specific occupational risks from vaccine-preventable diseases, and can improve adult immunization rates for non-occupational infectious diseases as well. However, costs, controversies and misinformation are challenges to successful workplace immunization programs. Workplace Immunization for Specific Worker Populations There is strong evidence and rationale for vaccination to mitigate a range of occupational biohazards in many worker populations. This talk will review recommended vaccines for healthcare personnel, animal workers, and laboratorians, and present strategies for successful workplace immunization in these settings that can be extended to other employee populations at risk. The history, current status, strengths, and challenges of occupational vaccine mandates will be considered using specific examples. Workplace Immunization Programs for Non-Occupational Diseases Occupational health programs which emphasize workplace immunization against occupational illnesses develop expertise and infrastructure for vaccine education, handling, storage, and administration. If they are able to create trust and support vaccine confidence among their employees, those resources can be extended to offer other recommended adult vaccines in this convenient and safe setting. Workplace immunization can support national and global adult immunization goals with broad implications for worker and community health. Conclusion Workplace immunization programs present a unique opportunity to reduce the risk of occupational infections, workplace disease transmission, and worker illness in general. Costs and operational demands may be substantial, but the potential short and long-term benefits to workers, employers, and communities are great.
No takes yet. Share an insight, caveat, or question.
Amy J. Behrman (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: